Lundbeck-backed injectable bone graft developer Bonesupport has attracted $14m for a funding round led by an unnamed Scandinavian pension fund.
Bonesupport, a Sweden-based developer of injectable bone substitutes to treat orthopaedic trauma and infections backed by pharmaceutical firm Lundbeck, closed a $14m funding round on Wednesday.
The round was led by an unnamed major Scandinavian pension fund, and also featured undisclosed existing investors.
Bonesuppport previously raised SEK 510m ($59.3m) from investors including Lundbeckfond Ventures, the investment arm of drug producer Lundbeck, Industrifonden, HealthCap, Teknoinvest, Vencorp Partners, NBGI Ventures, Ferd Venture and Innovations Kapita.
Founded in 1999 and based on research…
